These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21082260)

  • 81. Systematic analysis on the GSTM1 null phenotype and prostate cancer risk in Chinese people.
    Shi J; Zhuang Y; Liu Y; Yan CQ; Liu XK; Zhang Y
    Asian Pac J Cancer Prev; 2015; 16(5):2009-11. PubMed ID: 25773803
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men.
    Agalliu I; Langeberg WJ; Lampe JW; Salinas CA; Stanford JL
    Prostate; 2006 Feb; 66(2):146-56. PubMed ID: 16173036
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis.
    Carlsten C; Sagoo GS; Frodsham AJ; Burke W; Higgins JP
    Am J Epidemiol; 2008 Apr; 167(7):759-74. PubMed ID: 18270371
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Glutathione S-transferase M1 and T1 polymorphisms and cervical cancer risk: a meta-analysis.
    Wang D; Wang B; Zhai JX; Liu DW; Sun GG
    Neoplasma; 2011; 58(4):352-9. PubMed ID: 21520994
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Genetic polymorphisms of glutathione S-transferase P1 and bladder cancer susceptibility in a Chinese population.
    Zhang R; Xu G; Chen W; Zhang W
    Genet Test Mol Biomarkers; 2011; 15(1-2):85-8. PubMed ID: 21117956
    [TBL] [Abstract][Full Text] [Related]  

  • 86. GSTT1 and GSTM1 polymorphisms and prostate cancer risk in Asians: a systematic review and meta-analysis.
    Liu D; Liu Y; Ran L; Shang H; Li D
    Tumour Biol; 2013 Oct; 34(5):2539-44. PubMed ID: 23817691
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Meta-analysis on glutathione S-transferase M1 polymorphisms and the risk of esophageal cancer].
    Huang ZG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Oct; 25(10):898-901. PubMed ID: 15631753
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Genetic Polymorphism of GSTM1 and GSTT1 and Risk of Prostatic Carcinoma - a Meta-analysis of 7,281 Prostate Cancer Cases and 9,082 Healthy Controls.
    Malik SS; Kazmi Z; Fatima I; Shabbir R; Perveen S; Masood N
    Asian Pac J Cancer Prev; 2016; 17(5):2629-35. PubMed ID: 27268642
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Glutathione S-transferase T1 null genotype and laryngeal cancer risk: a meta-analysis.
    Li Q; Liu M
    Tumour Biol; 2014 Sep; 35(9):8781-5. PubMed ID: 24879623
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India.
    Srivastava DS; Kumar A; Mittal B; Mittal RD
    Arch Toxicol; 2004 Aug; 78(8):430-4. PubMed ID: 15057507
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Association of glutathione S-transferase T1 and M1 polymorphisms with prostate cancer susceptibility in populations of Asian descent: a meta-analysis.
    Cao DL; Ye DW; Dai B; Zhang HL; Shen YJ; Zhu Y; Zhu YP; Shi GH; Ma CG; Xiao WJ; Qin XJ; Lin GW
    Oncotarget; 2015 Nov; 6(34):35843-50. PubMed ID: 26416453
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Association of GST genetic polymorphisms with the susceptibility to hepatocellular carcinoma (HCC) in Chinese population evaluated by an updated systematic meta-analysis.
    Liu K; Zhang L; Lin X; Chen L; Shi H; Magaye R; Zou B; Zhao J
    PLoS One; 2013; 8(2):e57043. PubMed ID: 23437305
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Glutathione S-transferase M1 null genotype contributes to increased risk of esophageal carcinoma in Chinese population.
    Zhong S; Zhao W; Lu C; Li B; Yuan Y; Guo D; Chang Z; Jiao B; Yang L
    Tumour Biol; 2013 Aug; 34(4):2403-7. PubMed ID: 23625656
    [TBL] [Abstract][Full Text] [Related]  

  • 94. N-acetyltransferase 1 polymorphism and bladder cancer susceptibility: a meta-analysis of epidemiological studies.
    Wu K; Wang X; Xie Z; Liu Z; Lu Y
    J Int Med Res; 2013 Feb; 41(1):31-7. PubMed ID: 23569127
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Glutathione S-transferase M1 polymorphism and endometriosis susceptibility: a meta-analysis.
    Li H; Zhang Y
    J Gynecol Obstet Biol Reprod (Paris); 2015 Feb; 44(2):136-44. PubMed ID: 25443469
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer?
    Aktas D; Ozen H; Atsu N; Tekin A; Sozen S; Tuncbilek E
    Cancer Genet Cytogenet; 2001 Feb; 125(1):1-4. PubMed ID: 11297759
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis.
    Li W; Song LQ; Tan J
    Tumour Biol; 2014 Sep; 35(9):9281-90. PubMed ID: 24938875
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Association between GSTM1 polymorphisms and lung cancer: an updated meta-analysis.
    Liu H; Ma HF; Chen YK
    Genet Mol Res; 2015 Feb; 14(1):1385-92. PubMed ID: 25730077
    [TBL] [Abstract][Full Text] [Related]  

  • 99. P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians.
    Xu T; Xu ZC; Zou Q; Yu B; Huang XE
    Asian Pac J Cancer Prev; 2012; 13(5):2349-54. PubMed ID: 22901221
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Hypertension, diuretics and antihypertensives in relation to bladder cancer.
    Jiang X; Castelao JE; Yuan JM; Groshen S; Stern MC; Conti DV; Cortessis VK; Coetzee GA; Pike MC; Gago-Dominguez M
    Carcinogenesis; 2010 Nov; 31(11):1964-71. PubMed ID: 20732908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.